Episodic ataxia

What it is, symptoms and effects

From: MedlinePlus Genetics, National Library of Medicine

Episodic ataxia is a group of related conditions that affect the nervous system and cause problems with movement and coordination. People with episodic ataxia have episodes of poor coordination and balance (ataxia). During these episodes, many people also experience dizziness (vertigo), nausea and vomiting, migraines, blurred or double vision, slurred speech, and ringing in the ears (tinnitus). Seizures, muscle weakness, and paralysis that affect one side of the body (hemiplegia) may also occur during these episodes.

Additionally, a muscle abnormality called myokymia or an eye abnormality called nystagmus can occur during or between episodes. Myokymia causes muscle cramping; stiffness; or continuous, fine muscle twitching that appears as rippling under the skin. Nystagmus refers to rapid, involuntary eye movements.

Episodes of ataxia and other symptoms can begin anytime from early childhood to adulthood. They can be triggered by environmental factors such as stress, caffeine, alcohol, certain medications, physical activity, and illness. The duration of episodes may vary from seconds to days, and the frequency ranges from several episodes per day to one or two every few months. Between episodes, affected individuals may have no signs or symptoms. However, some continue to experience ataxia, which may worsen over time.

Some children with episodic ataxia have delayed development of speech or motor skills, such as standing and walking. They may also have learning difficulties.

Researchers have identified at least 11 types of episodic ataxia, distinguished by their pattern of signs and symptoms, age of onset, length of episodes, and genetic cause.

Causes and biological mechanisms

From: MedlinePlus Genetics, National Library of Medicine

Episodic ataxia can be caused by variants (also called mutations) in several genes that play important roles in the nervous system. Several of the genes provide instructions for making proteins that are involved in the transport of charged atoms (ions) across cell membranes. The protein produced from the KCNA1 gene transports potassium ions, and the protein produced from the CACNA1A gene transports calcium ions. The movement of these ions is critical for normal signaling between nerve cells (neurons) in the brain and other parts of the nervous system. Variants in the KCNA1 and CACNA1A genes cause episodic ataxia types 1 and 2, respectively.

Variants in the SLC1A3 gene cause episodic ataxia type 6. This gene provides instructions for making a protein that transports chloride ions across cell membranes. The movement of chloride ions is thought to help maintain certain cellular conditions so the cells can survive and function. The protein also transports a brain chemical (neurotransmitter) called glutamate. Neurotransmitters allow neurons to communicate by relaying chemical signals from one neuron to another.

Researchers believe that variants in the KCNA1, CACNA1A, and SLC1A3 genes alter the transport of ions in the brain. Changes in ion transport may cause certain neurons to become overexcited, disrupting normal communication between these cells. Although episodes of ataxia are caused by changes in the brain's chemical signals, it is unclear how variants in these genes cause the specific features of the disorder.

The genetic causes of other types of episodic ataxia have not been identified or are not well documented. Researchers are looking for variants in additional genes that can cause episodic ataxia.

Inheritance and family implications

From: MedlinePlus Genetics, National Library of Medicine

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

In some cases, an affected person inherits the variant from one affected parent. Other cases result from new variants in the gene and occur in people with no history of the disorder in their family.

How common is it?

From: MedlinePlus Genetics, National Library of Medicine

Episodic ataxia is uncommon, affecting less than 1 in 100,000 people. Only types 1, 2, and 6 have been identified in more than one family, and type 2 is by far the most common form of the condition.

Which doctor should you see?

The suggested department for discussing Episodic ataxia is Neurology, with a neurologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Which nervous-system findings help explain the symptoms?
• Would an assessment of walking, communication or daily function be helpful?
• Are rehabilitation or other specialist services relevant?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Episodic ataxia. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.